Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taro Pharm Inds (NY: TARO )

31.00 +0.67 (+2.21%)
Official Closing Price Updated: 7:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,778
Open 30.66
Bid (Size) 29.27 (1)
Ask (Size) 35.48 (1)
Prev. Close 30.33
Today's Range 30.59 - 31.04
52wk Range 27.50 - 51.08
Shares Outstanding 37,584,631
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Taro Provides Results for December 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For January 24, 2023
Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue of $327.63 million. 
Via Benzinga

Performance

YTD
+5.91%
+5.91%
1 Month
+6.68%
+6.68%
3 Month
+8.47%
+8.47%
6 Month
-8.85%
-8.85%
1 Year
-29.48%
-29.48%

More News

Read More
Taro Pharmaceutical Indus's Earnings Outlook
Via Benzinga
Taro to Release Third Quarter Results on January 24, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Provides Results for September 30, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Pharmaceutical Indus's Earnings: A Preview
Via Benzinga
Taro to Release Second Quarter Results on October 27, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Pharmaceutical Indus: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For October 27, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Taro Provides Results for the Quarter Ended June 30, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Via Benzinga
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro to Release First Quarter Results on July 27, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For July 27, 2022
Via Benzinga
Taro Provides Results for the Year Ended March 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Taro Pharmaceutical Indus Earnings Preview
Via Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Via Benzinga
Earnings Scheduled For May 26, 2022
Via Benzinga
Taro to Announce Full Year Results on May 26, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Taro to Acquire Alchemee From Galderma
From Galderma
Via Business Wire
10 Biggest Price Target Changes For Monday
Via Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.